News Agency
The Times

IASO Bio Announces U.S. FDA Approval of Investigational New Drug Application for BCMA CAR-T Equecabtagene Autoleucel for Generalized Myasthenia Gravis

  • Written by PR Newswire

SHANGHAI and NANJING, CHINA, and SAN JOSE, Calif., April 5, 2024 /PRNewswire/ -- IASO Biotechnology ("IASO Bio"), a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing innovative cell therapy and antibody products, is pleased to announce that the Investigational New Drug (IND) application for its BCMA...

Read more: IASO Bio Announces U.S. FDA Approval of Investigational New Drug Application for BCMA CAR-T...

Why Headless CMS Is Ideal for Scalable Digital Sales Experiences

Digital sales experiences have become a major part of how buyers discover, evaluate, and choose products or services. Buyers no longer rely only on direct conversations with sales representatives. They interact with websites, product pages, landing pages, emails, digital sales... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion